This Entry
PermalinkURI
URI Label
Revisions
Add to List
Edit Entry
Export:
XML
Archives
- January 2015 (12)
- December 2014 (2)
- November 2014 (2)
- September 2014 (4)
- June 2014 (7)
- May 2014 (6)
- March 2014 (1)
- March 2014 (1)
- February 2014 (9)
- January 2014 (7)
- December 2013 (4)
- November 2013 (5)
- September 2013 (14)
- June 2013 (15)
- May 2013 (7)
- April 2013 (19)
- March 2013 (21)
- March 2013 (47)
- February 2013 (19)
- January 2013 (17)
- December 2012 (10)
- November 2012 (12)
- September 2012 (8)
- August 2012 (17)
- July 2012 (16)
- June 2012 (14)
- May 2012 (15)
- April 2012 (9)
- March 2012 (4)
- March 2012 (5)
- February 2012 (4)
Authors
Sections
- - New section - (1)
- Completed Experiments (158)
- Experiments (174)
Mnr
- MNR101-110 (13)
- MNR111-120 (13)
- MNR51-60 (3)
- MNR61-70 (1)
- MNR81-90 (4)
- MNR91-100 (5)
- mnr121-130 (7)
Tools
Show/Hide QR CodeShow/Hide Keys
Repeat of See Synthesis of 4-(4-Methylpiperazin-1-yl)thieno[3,2-d]pyrimidine (AEW 55-1)
Procedure:
To MNR 99-3 (500 mg, 2.93 mmol, 1 equiv) in THF (3.5 mL) (ethanol (2.5 mL added to get the starting material into solution) was added 1-methylpiperazine (0.49 mL, 4.40 mmol, 1.5 equiv) at 0 ˚C and the reaction mixture was stirred overnight at room temperature. Volatiles were removed in vacuo and then the white suspension was dissolved in EtOAc, washed with a saturated aqueous solution of sodium hydrogen carbonate, brine, dried (MgSO4) and evaporated to give a yellow oil which solidified at the high vac to give a yellow solid
Data:
AEW 55-2, EtOAc.jpg
Hazard and Risk Assessment:
See Synthesis of 4-(4-Methylpiperazin-1-yl)thieno[3,2-d]pyrimidine (AEW 55-1)
Linked Posts
This post is linked by:
Attached Files
AEW 55-2, EtOAc.jpg